Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Arthralgia and CYP19A1[original query] |
---|
Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer. Cancer chemotherapy and pharmacology 2011 Nov 68 (5): 1263-71. Park In Hae, Lee Yeon-Su, Lee Keun Seok, Kim Sook-young, Hong Seung-Hyun, Jeong Jaeheon, Lee Hyewon, Ro Jungsil, Nam Byung- |
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast cancer research : BCR 2011 13 (1): R8. Mao Jun J, Su H Irene, Feng Rui, Donelson Michelle L, Aplenc Richard, Rebbeck Timothy R, Stanczyk Frank, DeMichele Ange |
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy. The Eurasian journal of medicine 2016 Feb 48 (1): 10-4. Mazzuca Federica, Botticelli Andrea, Mazzotti Eva, La Torre Marco, Borro Marina, Marchetti Luca, Maddalena Chiara, Gentile Giovanna, Simmaco Maurizio, Marchetti Pao |
Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. British journal of clinical pharmacology 2016 Oct . Gervasini Guillermo, Jara Carlos, Olier Clara, Romero Nuria, Martínez Ruth, Carrillo Juan Anton |
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast cancer research and treatment 2020 Jul . Borrie Adrienne E, Rose Finnley A, Choi Yun-Hee, Perera Francisco E, Read Nancy, Sexton Tracy, Lock Michael, Vandenberg Theodore A, Hahn Karin, Younus Jawaid, Logan Diane, Potvin Kylea, Yaremko Brian, Yu Edward, Lenehan John, Welch Stephen, Teft Wendy A, Kim Richard |
- Page last reviewed:Feb 1, 2024
- Content source: